Opioid addiction can develop in very different circumstances. One person may begin with medication after an injury; another may use heroin or an unknown tablet obtained outside healthcare. Some people continue working and managing family responsibilities while their relationship with opioids becomes increasingly difficult. An assessment should start with what is happening now, rather than assumptions about appearance, employment or the way use began.
This guide explains the distinction between physical dependence and opioid use disorder, the changes that warrant professional attention and the main questions to discuss when seeking help. It is an educational resource, not a diagnosis or a medication plan. For information about individual care, see private opioid addiction treatment and rehab.
What Are Opioids?
Opioids are a group of substances that act on opioid receptors. They include medicines used for pain, such as morphine, oxycodone and codeine, as well as heroin and illegally manufactured fentanyl. Some medicines in this group also have an important role in treating opioid use disorder. A substance being prescribed does not make every pattern of use safe; equally, receiving an opioid medicine does not automatically mean that someone has an addiction.
For a useful consultation, identify the actual products involved, the reasons they are taken and whether their source is reliable. Bring packaging or a medication list when available. Tell the clinician about non-prescribed substances as well as prescriptions, including products obtained online. Uncertainty about what a tablet contains is important information, not a reason to delay asking for help.
Physical Dependence Is Not the Same as Addiction
Physical dependence means that the body has adapted to repeated exposure and symptoms may occur when the medicine is reduced or stopped. Tolerance means that the response to a substance changes with repeated exposure. These processes can develop during prescribed treatment. Their presence alone should not be used to label a person as addicted.
Opioid use disorder involves a broader clinical assessment of problematic use and its consequences. The CDC’s diagnostic guidance specifically notes that tolerance and withdrawal do not count as diagnostic criteria when opioids are taken solely under appropriate medical supervision. The distinction matters because a person may need careful medication review and withdrawal support without needing the same treatment as someone experiencing compulsive, harmful use.
Changes That Deserve an Assessment
Useful questions include whether use repeatedly exceeds the person’s intention, whether attempts to reduce it have failed, and whether obtaining or recovering from opioids increasingly dominates daily life. Continued use despite damage to health, relationships or responsibilities also warrants attention. Craving and using in hazardous circumstances may be relevant. No single sign, and no online checklist, can establish the whole diagnosis.
Try to describe specific examples rather than choosing a label before the appointment. Explain what happened during the last unsuccessful attempt to cut down, what prompted returning to use and what has changed at home or work. A self-assessment resource may help organize that conversation, but should not replace a professional evaluation.
Pain and Addiction Can Require Different but Connected Care
Someone with ongoing pain may worry that disclosing problems with medication will result in their pain being dismissed. A good assessment needs to take both concerns seriously. It should consider the pain condition, previous investigations, the benefits and harms of current medication and any loss of control over use. Pain that continues during treatment is not proof of dishonesty or lack of motivation.
Prepare separate descriptions of the pain and the medication pattern. Which activities have become harder? What benefit does the medicine still provide? Are extra doses being taken for pain, withdrawal, sleep, emotional relief or several reasons? These questions can help the team coordinate chronic pain care with an appropriate addiction or prescribing pathway instead of treating one problem as if it cancels the other.
Recognizing an Overdose Emergency
Opioid overdose can suppress breathing. Warning signs include unresponsiveness, very slow or absent breathing, and blue or gray lips or skin. Call local emergency services immediately when overdose is suspected. Give naloxone if available, following its instructions and emergency-dispatch guidance. Do not wait to see whether the person simply wakes up.
SAMHSA’s overdose guidance emphasizes urgent medical attention. Naloxone is an emergency reversal medicine, not continuing addiction treatment, and its effect can wear off. People at risk and those close to them should discuss access and practical training with a clinician or pharmacist. A routine inquiry to a residential treatment provider is not an emergency response.
Why Other Substances Matter
Assessment should include alcohol, benzodiazepines, sleeping medication, stimulants and any other substances being used. Combining substances can change the risks and make symptoms harder to interpret. For example, sedation should not be dismissed as ordinary tiredness, and stopping several medicines at once should not be treated as a simple way to accelerate recovery.
The FDA warns about serious risks from combining opioids with benzodiazepines or other central nervous system depressants. Share the complete medication and substance history with the prescriber. Do not make unsupervised changes to prescribed treatment in response to a general warning; seek an individual review that considers both interaction risk and withdrawal risk.
What a Thorough Assessment Should Cover
Useful information includes current substances, route of use, frequency, previous overdoses, withdrawal experiences, existing medical conditions and past treatment. The clinician may also ask about mood, sleep, trauma, self-harm, relationships, housing and practical support. Questions about infection or sexual health should be explained respectfully and connected to the person’s actual history.
Someone arranging care can prepare by gathering previous discharge letters, medication lists and the contact details of current clinicians. They should also explain any upcoming travel or interruptions in prescription access. Assessment and treatment planning should identify who is responsible for each decision, which setting is appropriate and what must happen before a residential admission can be considered.
Medication Is an Important Treatment Option
Evidence-based treatment for opioid use disorder can include buprenorphine, methadone or naltrexone, selected by an appropriately qualified clinician. These medicines have different roles, requirements and risks. Medication decisions must account for the current opioid exposure, other medicines, physical health, the person’s preferences and the arrangements for continuing care.
The CDC recommends offering or arranging evidence-based medication treatment. Receiving such treatment is not a failure of recovery and should not be described as merely substituting one addiction for another. Ask a prospective provider how existing medication will be reviewed, who can prescribe and how uninterrupted access will be arranged after treatment or international travel.
Why Detox Is Not the Whole Treatment
Withdrawal management addresses a period of physiological adjustment. It does not, by itself, resolve the factors that maintain opioid use or provide lasting protection from overdose. The CDC advises against detoxification alone for opioid use disorder because of the risks associated with returning to use without ongoing evidence-based treatment.
Before agreeing to any detoxification plan, ask what happens immediately afterward. The answer should include continuing clinical care, medication options, overdose prevention and support for the circumstances that previously led to use. A provider should explain the longer pathway, not only describe how comfortable the first few days might be. Finishing a short program is not the same as having a workable plan for the next several months.
Psychological and Practical Support
Useful psychological work may explore triggers, decisions around use, coping with distress and rebuilding everyday routines. The person may also need treatment for an independent mental-health condition. Those needs should be assessed rather than assuming that every emotional symptom will disappear after stopping opioids.
Practical planning can be equally important. A return home may involve access to substances, unresolved pain, family conflict, work demands or unreliable follow-up arrangements. Treatment should translate goals into specific support: who will provide prescriptions, how appointments will be maintained and what to do when craving or difficulties return. Relevant dual-diagnosis care should be coordinated with the addiction plan rather than left to a separate, unspecified future referral.
Family Involvement Without Blame
Family members may feel frightened, angry or uncertain about what help is useful. They can often provide valuable observations, but treatment should not become an argument about who caused the problem. The person receiving care retains confidentiality rights, and arrangements for sharing information should be agreed explicitly.
A helpful conversation focuses on observable concerns and practical support. Ask what an overdose plan should include, how to respond to deterioration and which boundaries are realistic. Avoid using access to urgent medical help or prescribed treatment as leverage. Relatives may need support of their own, whether or not the person is ready to enter a particular program.
Choosing a Setting and Planning the Next Step
Residential treatment is not automatically the safest or most useful setting for every person. Some need hospital assessment, medically supported withdrawal or another specialist pathway first; others can receive effective ongoing treatment locally. Ask how suitability is assessed and what the provider cannot safely manage.
THE BALANCE’s entry criteria and continuing-care approach provide context for discussing an individual referral. The immediate objective is an appropriate assessment and a credible, connected care plan, not choosing a treatment label in isolation.
